Bioengine Capital Inc. Insider Profile
4 Followers
Bioengine Capital Inc., Ten Percent Owner at Windtree Therapeutics, holds 0.00 shares in Windtree Therapeutics (Ticker: WINT).
Bioengine Capital Inc.'s Trading History
| WINTWindtree Therapeutics | Jan 10, 2022 | Ten Percent Owner | Uninformative Sell | ― | $0.00 | |
You May Also Like
Bioengine Capital Inc. insider profile FAQ
What is the percentage of profitable transactions made by Bioengine Capital Inc.?
The percentage of profitable transactions made by Bioengine Capital Inc. is 0%.
What is the average return per transaction made by Bioengine Capital Inc.?
The average return per transaction made by Bioengine Capital Inc. is -42.30%.
What stocks does Bioengine Capital Inc. hold?
Bioengine Capital Inc. holds: WINT stocks.
What was Bioengine Capital Inc.'s most profitable transaction?
Bioengine Capital Inc.’s most profitable transaction was an Informative Sell of WINT stock on January 10, 2022. The return on the trade was 0.00%.
What is Bioengine Capital Inc.'s role in Windtree Therapeutics?
Bioengine Capital Inc.'s role in Windtree Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
